day 1 agenda

Mon , Jun 10, 2019

  • 08:00
  • Registrations

  • 08:30
  • Opening Ceremony

  • 08:45
  • Welcome Speech

  • 09:00
  • Keynote Talk-1 : 3D Printed Corneal Equivalent

    Sachdeva Mandip S, Professor of Pharmaceutics, Florida A&M University, USA

  • 09:30
  • Keynote Talk-2 : Material properties impacting micronization behavior of a crystalline drug

    Ajit Narang, Sr. Scientist, Genentech, Inc., USA

  • 10:00
  • Keynote Talk-3 : Use of Cyclodextrin as a Novel Agent in the SEC-HPLC Mobile Phase to Mitigate the Interactions of Proteins or Peptide or their Impurities with the Residual Silanols of Commercial SEC-HPLC Columns with Improved Separation and Resolution.

    Kaliappanadar Nellaiappan, Director of Product Development at Curirx inc, USA

     

  • 10:30
  • Keynote Talk 4 : Preparation and nanoformulation of new quinolone scaffold-based anticancer agents: Enhancing solubility for better cellular delivery.

    Reem K. Arafa, Professor of Biomedical Sciences, Zewail City of Science and Technology, Egypt

  • 11:00
  • Group photo

  • 11:10
  • Refreshments

  • 11:40
  • Scientific session : A Pharmacokinetic Study of Medazolam and Ketamine in Patients on Extracorporeal Membrane Oxygenation Therapy

    Gagan Kaushal, Associate Professor in Pharmaceutics, Thomas Jefferson University, USA

  • 11:20
  • Scientific Session: Transdermal delivery of CZ48, camptothecin derivative, for anti-neoplastic indications: in vitro and in vivo evaluations

    Yousif Rojeab, Associate Professor of Pharmaceutics, Ohio Northern University, USA

  • 12:00
  • Scientific Session : Biorelevant Dissolution to Facilitate Formulation Development of a BSC Class 2 Basic Compound and Overcome Drug-Drug Interaction with Acid Reducing Agents

    Dawen Kou, Senior Scientist in Genentech at South San Francisco, CA, USA

  • 12:20
  • Scientific session : Subcutaneous formulation of furosemide: endless opportunities for an old drug.

    Tamas Alexy, Assistant Professor, Medicine/Cardiology, University of Minnesota, USA

  • 12:40
  • Speaker Slot Available

  • 13:00
  • Lunch With Round table Discussions

  • 14:00
  • Scientific session : Amino acid based surfactants: a class of amphiphiles with potential applications in the pharmaceutical field

    Diego Romano Perinelli, School of Pharmacy, University of Camerino, Italy

  • 14:40
  • Scientific Session : Marine Compound Xyloketal B as a Novel Drug Candidate for Cardiovascular and neuronal protection

    Guan-Lei Wang, Professor of Pharmacology, Sun Yat-sen University, China

  • 15:00
  • Scientific Session : In vitro lung epithelial cell transport and anti-interleukin-8 releasing activity of liposomal ciprofloxacin

    Ruba S. Darweesh, Assistant Professor of Pharmaceutical Sciences, Jordan University of Science and Technology, Jordan

  • 15:20
  • Scientific Session : Divorce uses of gabapentenoids and it’s implications- a new public health issue

    Shubhakaran Khichar, Professor of Neurology at Government Medical College, India

  • 15:40
  • Speaker Slot Available

  • 16:00
  • Refreshments

  • 16:20
  • Scientific Session : Targeting c-MYC and c-MYC regulating microRNAs in ovarian cancer with liposomal-interference RNA

    Pablo Vivas-Mejia, Assistant professor in the Cancer Center and the Department of Biochemistry of the University of Puerto Rico Medical Sciences, Puerto Rico

  • 16:40
  • Speaker Slot Available

  • 17:00
  • Panel Discussion

  • Note:
  • This is the tentative program and Program schedule is subjected to change with final allotment of speaker slots

day 2 agenda

Tue , Jun 11, 2019

  • 08:30
  • Registrations

  • 9:00
  • Keynote Talk-1: Bridging Discovery program to Development-The Making of a Phase I Trial Study

    Elizabeth Kwong,  Director & CEO of Kwong Eureka Solutions, Canada

  • 9:30
  • Keynote Talk-2: Therapeutic potentials of Resveratrol in its pro-oxidant incarnation in presence of copper

    Professor Indraneel (Neel) Mittra, Dr. Ernest Borges Chair in Translational Research and Professor Emeritus,Tata Memorial Centre, India

  • 10:30
  • Keynote Talk-3 : Development of a novel anti-Ran-GTPase peptide nanoparticles as a novel approach for anti-metastatic therapies

    Ahmed Faheem, School of Pharmacy and Pharmaceutical Sciences University of Sunderland, UK

  • 10:30
  • Keynote Talk 4 : A Novel Risk Management Approach to Managing Product Safety and Quality in the Pharmaceutical Drug Industry

    Ramakrishnan Narasimhan, Enarkay Management Solutions Inc.,Canada 

  • 11:00
  • Refreshments

  • 11:15
  • Scientific Session : Cell-based chemoresistance models to evaluate combinational nanoformuations

    Badiree Konkimalla, Reader-F, National Institute of Science Education and Research (NISER), India

  • 11:35
  • Speaker Slot Available

  • 11:55
  • Scientific Sessions : Our smeared FE computational models for drug delivery in organs and tumors

    Milos Kojic, Houston Methodist, BioIRC Research Center, Serbian Academy of Sciences and Arts, Serbia

  • 12:15
  • Scientific Sessions : Treatment of animal model for hot flushes by nasal administration of a non-hormonal drug delivery system

    Hiba Natsheh, Post-doctoral fellow at The Hebrew University, Israel

  • 12:35
  • Scientific Session: Relationship between Cancer, Microorganisms, and Platelets, Highlights about ‘Death Triangle’ and side effects of Therapeutic drugs

    Bahram Alamdary Badlou, PhD Hematology, BBAdvies and Research, Research and development Dept. Zeist, The Netherlands

  • 12:55
  • Scientific Session: 'Real-life' study of imatinib therapy in chronic phase-chronic myeloid leukemia: A novel retrospective observational longitudinal analysis.

    Serena Merante, Medical director at the IRCCS Policlinico San Matteo Pavia Foundation, Italy

  • 13:15
  • Lunch with Round table Discussions

  • 15:00
  • Scientific Session: Structure and mechanism-based design of nanoparticles as therapeutic candidates

    Chang-Guo Zhan, Molecular Modelling and Biopharmaceutical Center, College of Pharmacy, University of Kentucky, USA

  • 15:20
  • Speaker Slot Available

  • 15:40
  • Speaker Slot Available

  • 16:00
  • Refreshments

  • 16:35
  • Scientific Session: Evaluating a novel drug delivery system for oral amoxicillin

    Nadeem Ahmad, Quality Associate in Advanced Product design Services Inc., Canada

  • 16:55
  • Speaker Slot Available

  • 17:15
  • Scientific Session: Saffron-based cancer prevention is now in sight

    Amr Amin, UAE University, UAE

  • 17:35
  • Scientific Session: The potential utility of aqueous extract of stevia rebaudiana Bertoni in adjunct with metformin in treating diabetes mellitus

    Abdel-Azim Assi, Department of Pharmacology, Assiut University, Egypt

  • 17:55
  • Panel Discussion

  • Note:
  • This is the tentative program and Program schedule is subjected to change with final allotment of speaker slots

day 3 agenda

Tue , Jun 11, 2019

  • 9:00
  • Scientific Session: Quality of Life among Patients Undergoing Hemodialysis in Penang, Malaysia

    Diana Laila Rama, Department Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia.

     

  • 9:20
  • Speaker Slot Available

  • 09:40
  • Scientific Session: Evaluating the Appropriate Use of Pip/Taz in Cardiac Center of King Fahad Medical Center

    Mekdad Sanaa Saeed, Senior and Clinical Pharmacist, Department of Pharmacy, King Fahad Medical City, Saudi Arabia.

  • 12:40
  • Scientific Session: Analysis 3-Hydroxypropyl Mercapturic Acid (3-HPMA) in Urine of Breast Cancer Patient for Monitoring the Toxicity of Cyclophosphamide

    Yahdiana Haraha, Faculty of Pharmacy, Universitas Indonesia, Indonesia

  • 10:00
  • Speaker Slot Available

  • 10:20
  • Refreshments

  • 10:40
  • Scientific Session: Predicting Tumor Sensitivity to Chemotherapeutic Drugs in Oral Squamous Cell Carcinoma Patients

    N. Rajendra Prasad, Department of Biochemistry and Biotechnology, Annamalai University, India.

  • 11:00
  • Speaker Slot Available

  • 11:20
  • Scientific Session: Therapeutic oligoribonucleotides: pharmacological activity and mechanism of their action

    Zenoviy Tkachuk, Institute of Molecular Biology and Genetics, National Academy of Sciences of Ukraine, Ukraine

Conference Agenda Download